POZ - Treatment News : Accurate Immune System Marker in Poor Countries
Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » Treatment News » May 2007

Web Exclusives

AIDS Advocates Debate Obama's Policies

Evaluating the Costs of Earlier HIV Treatment

HIV Prevention Gets “Fergalicious”

» More

Most Talked About

Magic Johnson Accused of Faking HIV (42)

Guidelines Prediction: Start Treatment Earlier (blog) (19)

My First Facebook Demo (blog) (18)

World AIDS Day: Your Feedback (14)

Bone Marrow Transplant: Potential AIDS Cure? (9)

Obama Campaign Set to Boost Domestic HIV/AIDS Funding (8)

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Herpes Simplex Virus

Human Papilloma Virus (HPV)

Shingles

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

10 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrssprint

May 18, 2007

Accurate Immune System Marker in Poor Countries
(Reuters Health)

A new algorithm based on components of a complete blood cell count (CBC) gives a better estimate of CD4 cell count in HIV patients than estimates using the total lymphocyte count (TLC), recommended by the World Health Organization, according to a report in the April 15th issue of the Journal of Acquired Immune Deficiency Syndromes.

A TLC of 1,200 cells/mL or less has been used as a surrogate for a CD4 cell count of 200 cells/microliters or less in settings where resources are limited and there is no ability to measure CD4 cell count. However, some studies have shown that TLC-based estimates can have a poor correlation with actual CD4 cell count.

Dr. Ray Y. Chen and colleagues at the University of Alabama at Birmingham (UAB) and elsewhere developed a decision tree based on multiple components of the CBC -- including TLC, hemoglobin and platelet count -- and adjusted for gender, body mass index (BMI) and antiretroviral therapy status.

The algorithm was developed from complete blood counts obtained from 1,189 patients attending the UAB Outpatient HIV Clinic since 1994. Results were compared with blood samples from Zambia and the Birmingham Veterans Affairs Medical Center.

Dr. Chen and colleagues report that the "UAB-based decision tree performed better than the TLC cutpoint of 1,200 cells/mL" in the BVAMC and Zambian samples.

The investigators caution that "a given model is not always applicable in another population." They say additional studies may show that "the best model to identify a low CD4 cell count may be one based on local data."

This or a similar model provides a reliable, affordable method of estimating CD4 cell counts in HIV-infected patients in resource-limited areas, the team concludes.

J Acquir Immune Defic Syndr 2007;44:525-530.



Copyright© 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

emailrssprint


[Go to top]


Get Started
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Talk to Us
Weekly Poll
Question: Would legalizing prostitution reduce the spread of HIV?
Yes
No
I don't know.

Monthly Poll
Question: Do you believe that prisoners receive adequate health care?
Yes
No
I don't know.

Surveys
Tell us about your overall health habits.

Tell us when and to whom you disclose your status.

more surveys
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy